Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients

Clinical trial NCT00888004 · COMPLETED

Trial details

NCT number: NCT00888004
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson's Disease L-dopa Induced Dyskinesia

Start date: 2009-03-01
Primary completion: 2009-08-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.